GlobeNewswire by notified

Bonduelle - Quarter 3 FY 2023-2024 Revenue: Business activity slightly down on Quarter 3 in a climate of constrained consumption

Share

BONDUELLE

Head office: "La Woestyne" - 59173 Renescure - France
Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros
Registered under number : 447 250 044 (Dunkerque Commercial and Companies Register)


Quarter 3 FY 2023-2024 Revenue

Bonduelle Group: Business activity slightly down on Quarter 3 in a climate of constrained consumption

The Bonduelle Group's revenue stands for Quarter 3 of FY 2023-2024 (from January 1, to March 31, 2024) at 564.9 million euros, thus a downturn compared with the previous fiscal year (572.2 million euros) of -1.3% on reported figures and -1.0% on a like-for-like basis*.

No change in the scope of consolidation occurred over the period.

Over the 9 first months, the revenue amounted to 1,778.0 million euros, down -2.1% on reported figures and up +2.8% on a like-for-like basis* after taking into account currency variations (significant depreciation of the ruble and weakening of the US dollar against the euro compared with the same period last year).

This growth is mainly due to the good performance of the long life activity in both can and frozen segments. On the other hand, the fresh processed activities declined, mainly in North America.

Activity by Geographical Region

Total Consolidated Revenue
(in € millions)
9 months
2023-2024
9 months
2022-2023
Variation
Reported figures
Variation
Like-for-like basis*
3rd quarter
2023-2024
3rd quarter
2022-2023
Variation
Reported figures
Variation
Like-for-like basis*
Europe Zone1,165.21,115.94.4%3.9%378.8376.80.5%0.0%
Non-Europe Zone 612.8699.6-12.4%1.0%186.1195.4-4.7%-3.0%
Total1,778.01,815.5-2.1%2.8%564.9572.2-1.3%-1.0%

Activity by Operating Segments

Total Consolidated Revenue
(in € millions)
9 months
2023-2024
9 months
2022-2023
Variation
Reported figures
Variation
Like-for-like basis*
3rd quarter
2023-2024
3rd quarter
2022-2023
Variation
Reported figures
Variation
Like-for-like basis*
Canned854.9860.5-0.7%6.8%260.2263.4-1.2%-1.8%
Frozen227.3211.97.2%8.9%78.473.46.8%8.2%
Fresh processed695.8743.1-6.4%-3.6%226.3235.4-3.9%-3.0%
Total1,778.01,815.5-2.1%2.8%564.9572.2-1.3%-1.0%

Europe Zone

The Europe Zone representing 65.5% of the business activity at the end of the 9 first months, posted an overall growth of +4.4% on reported figures and +3.9% on a like-for-like basis*, with Quarter 3 recording an evolution of +0.5% and +0.0% respectively.

The consumption under pressure in Europe Zone over the last quarter led to a downturn in volumes over the period particularly strong in retail for both branded and private label products.

At the end of the first 9 months of fiscal year, the growth of the business activity remained solid, mainly driven by a notable performance in branded food service, in both can and frozen.

Fresh activities posted a slight increase in volume and value over the quarter, fueled by a good performance in the fresh processed segment (bagged salads) in Italy. In France, the fresh prepared segment posted a solid performance in both Quarter 3 and over the 9 first months of the fiscal year.

Non-Europe Zone

The revenue of the Non-Europe Zone, representing 34.5% of the business activity over the first 9 months, recorded a variation of -12.4% on reported figures and +1.0% on a like-for-like basis*, Quarter 3 posted an evolution of -4.7% and -3.0% respectively.

Over Quarter 3, the Eurasia region reported growth in terms of volumes and value driven by the Bonduelle brand can segment and a sharp acceleration in frozen, both in retail and food service, the business activity in North America remains in decline in volumes over the period.

At the end of the first 9 months, the Non-Europe Zone business activity posted an evolution of -12.4% on reported figures, due to the significant depreciation of the Russian ruble compared with the same period last year, and +1.0% on a like-for-like basis*.

Outlook

Given the current climate of consumption, the group is limiting its business revenue growth objective between +3% and +4%, while its recurring operating income growth target remains unchanged at around +15%, both on a like-for-like basis*.

(*) at constant currency exchange rate and scope of consolidation basis. The revenues in foreign currency over the given period are translated into the rate of exchange for the comparable period. The impact of business acquisitions (or gain of control) and divestments is restated as follows:

  • For businesses acquired (or gain of control) during the current period, revenue generated since the acquisition date is excluded from the organic growth calculation;
  • For businesses acquired (or gain of control) during the prior fiscal year, revenue generated during the current period up until the first anniversary date of the acquisition is excluded;
  • For businesses divested (or loss of control) during the prior fiscal year, revenue generated in the comparative period of the prior fiscal year until the divestment date is excluded;
  • For businesses divested (or loss of control) during the current fiscal year, revenue generated in the period commencing 12 months before the divestment date up to the end of the comparative period of the prior fiscal year is excluded.

Alternative performance indicators: the group presents in its financial notices performance indicators not defined by accounting standards. The main performance indicators are detailed in the financial reports available on www.bonduelle.com

Next financial events:

- 2023-2024 Fiscal Year Revenue: August 1, 2024 (after market closing)
- 2023-2024 Annual Results:September 27, 2024 (after market closing)
- Analysts and investors meeting: September 30, 2024

About the Bonduelle Group

We want to inspire the transition toward a plant-rich diet, to contribute to people’s well-being and planet health. We are a French family business with 11,038 full-time equivalent employees and we have been innovating with our farming partners since 1853. Our products are cultivated on 68,316 hectares and sold in nearly 100 countries, for revenue of 2,406.2 million euros (data as of June 30, 2023)

Our 4 flagship brands are: BONDUELLE, READY PAC FOODS, CASSEGRAIN and GLOBUS.


Bonduelle is listed on Euronext Paris compartment B
Euronext indices: CAC MID & SMALL – CAC FOOD PRODUCERS – CAC ALL SHARES
Bonduelle is part of the Gaïa non-financial performance index and employees shareholder index (I.A.S.)
Code ISIN: FR0000063935 - Code Reuters: BOND.PA - Code Bloomberg: BON FP

This document is a free translation into English and has no other value than an informative one. Should there be any difference between the French and the English version, only the French-language version shall be deemed authentic and considered as expressing the exact information published by Bonduelle.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye